D-0374-2024 Class II Terminated

Recalled by Thea Pharma, Inc. — Waltham, MA

FDA drug recall D-0374-2024 was initiated by Thea Pharma, Inc. on Mar 5, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Out of specification for volume and compromised container closure. The recall status is terminated (terminated Jun 30, 2025). Affected quantity: 5,476 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2024
Initiation Date
Mar 5, 2024
Termination Date
Jun 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,476 bottles

Product description

Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15

Reason for recall

Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

Distribution pattern

Product was distributed nationwide within the United States

Code information

Lot #: 435019, Exp. Date 11/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0374-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0374-2024. Report a data issue: hello@regdatalab.com.